 |
|
|
|
 |
|
|
 Kontakt |  Druckansicht |  PDF-Ansicht |  Firma weiterempfehlen
|
300 Technology Square
02139 Cambridge, MA
Vereinigte Staaten von Amerika
|
|
Portrait
Dyax is focused on advancing novel biotherapeutics for unmet medical needs, with an emphasis on oncology and inflammatory indications. Dyax utilizes its proprietary drug discovery technology to identify antibody, small protein and peptide compounds for clinical development.
Dyax is headquartered in Cambridge, Massachusetts, and has antibody discovery facilities in Liege, Belgium.
Branchenbereiche
Weitere Informationen
Dyax Corp.
Cambridge, MA, Vereinigte Staaten von Amerika
News
|
|
|
|
|
|
Top
